Author Archives: Sara Agee Le

April 16, 2019
Press Release

Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development   GENEVA, Switzerland and SAN FRANCISCO, USA (April 16, 2019) – Atomwise, Inc., a biotech company using artificial intelligence (AI) for drug discovery, and the Drugs for Neglected […]

Read Article
April 9, 2019
Press Release

A half dozen University of Connecticut (UConn) researchers are now working to identify potential new drugs to treat a wide range of diseases and conditions through a unique partnership that offers access to cutting-edge artificial intelligence (AI) technology and screening compounds at no cost. The researchers have been using Atomwise’s AI-powered in silico screening technology […]

Read Article
June 1, 2018
Press Release

Following a successful first year supporting 100 pioneering research projects, Atomwise opens a new round of awards to academic researchers. Atomwise Inc., a leader in using Artificial Intelligence (AI) for drug screening and design, has announced that 100 academic projects have received an Artificial Intelligence Molecular Screen (AIMS) Award in the first year of the […]

Read Article
March 7, 2018
Press Release

Atomwise Inc. today announced it has raised $45 million of growth funding, led by Monsanto Growth Ventures, DCVC (Data Collective), and B Capital Group, in support of its mission to become the preferred artificial intelligence partner for the world’s leading pharmaceutical, biotech, and agrochemical companies. Prior investors, including Y Combinator, Khosla Ventures, and DFJ participated […]

Read Article
June 14, 2017
Press Release

Monsanto Company and Atomwise have formed a unique research collaboration to increase the speed and probability of discovering and developing new crop protection products using artificial intelligence. “Each growing season, farmers around the world are challenged with yield-robbing pests and diseases, yet the average crop protection product takes up to 11 years and more than […]

Read Article
April 9, 2017
Press Release

New initiative puts potential medicines chosen by artificial intelligence into the hands of one hundred researchers San Francisco, CA – April 19, 2017 – Atomwise Inc. seeks proposals from innovative university scientists to receive 72 potential medicines, generated specifically for their research by artificial intelligence. The Artificial Intelligence Molecular Screen (AIMS) program is designed to […]

Read Article